Amarantus Bioscience Holdings Inc (AMBS)

[jason_luke]

* .0001 higher. GO AMBS. Also love the new article making noise about blood-based tests for Parkinson's. Not many being developed, and NuroPro has shown a great deal of effectiveness in early human trials. I personally think someone would want the IP here, and AMBS has a lot it, including another approved NuroPro patent just a couple weeks ago.

MANF in my opinion could be an astounding breakthrough in treating Parkinson's via gene therapy. Every single article I have read on it, and there are A LOT of them, is supremely positive. Seems like a new journal article on MANF and its great potential in treating Parkinson's (as well as eye diseases such as retinal pigmentosa - see article published in NATURE last summer) comes out each month. And AMBS is not sponsoring these scientific articles, it is 100% independent research.

Time will tell.